BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
7.14
-0.43 (-5.68%)
At close: Jul 11, 2025, 4:00 PM
7.05
-0.09 (-1.26%)
After-hours: Jul 11, 2025, 7:57 PM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $13.24 million as of July 11, 2025. Its market cap has decreased by -54.19% in one year.
Market Cap
13.24M
Enterprise Value
-9.55M
1-Year Change
-54.19%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $13.24M, a decrease of -74.54%. That is a compound annual growth rate of -24.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 14.10M | -60.28% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |